819-P: A Novel Premix Insulin GZR101 for Diabetes Management

内科学 内分泌学 胰岛素 脱胶胰岛素 化学 血糖性 糖尿病 人血清白蛋白 脂肪生成 体内 基础(医学) 基础胰岛素 医学 2型糖尿病 生物 脂肪组织 生物化学 生物技术
作者
Wei Chen,Wancai Xing,Yining Zhang,Anshun He,JING GAO,QIMIN SHI,Fangkai Xue,YONGCHUN WANG,Jun Zhang,DONGLI YU,Cheng Cui,TIAN XIE,ZHONGRU GAN
出处
期刊:Diabetes [American Diabetes Association]
卷期号:73 (Supplement_1)
标识
DOI:10.2337/db24-819-p
摘要

Introduction: Inadequate glycemic control in patients with premix insulin regimen is often due to the short half-life and pronounced peak-to-trough ratio of basal insulin. This necessitates the development of a premix insulin containing basal insulins with an extended half-life and steady pharmacokinetic (PK) profile. Objective: This study evaluated and characterized GZR33, an ultra-long half-life basal insulin, and GZR101 which is composed by GZR33 and insulin aspart. Methods: The binding affinity of GZR33 to the human insulin receptor (hIR) was analyzed in vitro using surface plasmon resonance. IR activation was examined in CHO cells in the presence and absence of human serum albumin (HSA). Adipogenesis was measured in 3T3L1 MBX cells. Potency was tested in vivo in streptozotocin-induced T1DM rats and db/db T2DM mice, using insulin degludec (iDeg) and iDegAsp as controls. PK studies were assessed in Sprague-Dawley rats. Results: GZR33 was constructed by linking a C22 fatty diacid side chain to desB30 human insulin via a 6×OEG linker. GZR33 exhibited strong hIRA and hIRB binding (dissociation constants: 2.86E-6 M and 1.28E-6 M). It activated IRA and IRB with EC50 of 370.13 ± 94.86 nM and 477.48 ± 64.28 nM, respectively, in 0.5% HSA, and induced adipogenesis with an EC50 of 2.45 ± 0.81 nM. PK studies showed a dose-dependent increase in maximum concentration and exposure, with a T½ of 5.45 h for GZR33 (2.3 h for iDeg). In T1DM rats and T2DM mice, GZR33 outperformed iDeg in reducing HbA1c and FBG, demonstrating a potency at least three-fold higher than iDeg. Additionally, GZR101's glucose-lowering effect was proportional to the GZR33 dosage in diabetic models. Conclusion: Traditional basal insulins display a 24-hour glucose-lowering effect with noticeable peaks, leading to fluctuating blood glucose in patients. However, a basal insulin with over 3-day longevity and once-daily dosing, like GZR33, can achieve a nearly peak-less PK profile at steady-state. Consequently, GZR101 emerges as a promising once-daily premix insulin candidate. Disclosure W. Chen: None. W. Xing: None. Y. Zhang: None. A. He: None. J. Gao: None. Q. Shi: None. F. Xue: None. Y. Wang: None. J. Zhang: None. D. Yu: None. C. Cui: None. T. Xie: None. Z. Gan: None.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
ZZICU完成签到,获得积分10
3秒前
yun尘世发布了新的文献求助10
3秒前
量子星尘发布了新的文献求助10
4秒前
4秒前
6秒前
罗拉发布了新的文献求助10
6秒前
7秒前
7秒前
鱼e完成签到,获得积分10
9秒前
9秒前
10秒前
10秒前
song发布了新的文献求助10
12秒前
ding应助时尚初之采纳,获得10
12秒前
罗拉完成签到,获得积分10
12秒前
12秒前
13秒前
yun尘世完成签到,获得积分10
14秒前
14秒前
自信南霜完成签到,获得积分10
14秒前
tingting9完成签到,获得积分10
17秒前
17秒前
18秒前
卡布奇诺完成签到,获得积分10
18秒前
13223456发布了新的文献求助10
18秒前
青山落日秋月春风完成签到,获得积分10
20秒前
21秒前
22秒前
22秒前
小马甲应助动听的雅绿采纳,获得30
23秒前
1177发布了新的文献求助10
25秒前
25秒前
喜喵喵完成签到,获得积分10
26秒前
26秒前
26秒前
26秒前
11关注了科研通微信公众号
27秒前
123456完成签到,获得积分10
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989242
求助须知:如何正确求助?哪些是违规求助? 3531393
关于积分的说明 11253753
捐赠科研通 3270010
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136